• Title/Summary/Keyword: 편평세포

Search Result 607, Processing Time 0.028 seconds

Study on expression of HSP27 in squamous cell carcinoma of larynx (후두 편평 세포암에서의 HSP27 발현에 관한 연구)

  • 박경호;김민식;선동일;조승호;이정화
    • Korean Journal of Bronchoesophagology
    • /
    • v.7 no.1
    • /
    • pp.24-28
    • /
    • 2001
  • Background and Objectives: Heat shock protein(HSP) 27 is a member of the small HSP family that plays a part in the epithelial cell growth and differentiation, wound healing. apoptosis and cell protection against inflammatory cytotoxic mediators. The expression of HSP27 was investigated in normal laryngeal tissue and squamous cell carcinoma of the larynx. Materials and Methods : We studied expression of HSP27 by Western blot on 20 patients of laryngeal squamous cell carcinoma. Results: HSP27 expressed in all normal and cancer tissues. In 9 cases(45%), expression of HSP27 more prominent in cancer tissue. Statistically, there were no significant difference in the expression of HSP27 in normal and cancer tissue, clinical stage and tumor differentiation. Conclusion 45% of cancer tissues was more prominent than normal tissue. But further studies on expression of HSP27 in laryngeal cancer and relationship with clinical parameter should be done.

  • PDF

A Clinical Experience of Direct Extension to Parotid Gland of Cutaneous Squamous Cell Carcinoma (귀밑샘을 침범한 피부 편평세포암종의 치험례)

  • Lim, Hyo Seob;Kim, Jong Myung;Chung, Jai Ho
    • Archives of Plastic Surgery
    • /
    • v.32 no.5
    • /
    • pp.641-644
    • /
    • 2005
  • Cutaneous squamous cell carcinoma has a high incidence. However, regional metastasis occurs infrequently because skin cancer is usually recognized and treated early. We report the case of squamous cell carcinoma around the earlobe in a 74-year-old male patient. The cutaneous squamous cell carcinoma invaded ipsilateral parotid gland directly without lymphatic spreading. Wide excision was made with 1.5 cm margin and immediate reconstruction was performed with radial forearm fasciocutaneous free flap. During operation facial nerve was preserved. No recurrence was noted for 5 years and the patient was satisfied with good aesthetic result. Cutaneous squamous cell carcinoma spreads to the parotid gland usually through lymph nodes and there are few reports of invasive organ damage by direct invasion. We experienced a case of direct invasion to parotid gland without lymph node involvement of cutaneous squamous cell carcinoma and treated the cancer adequately with wide excision and free flap coverage.

Squamous Cell Carcinoma of Thyroid Gland Associated with Esophageal Carcinoma -Diagnostic Dilemma- (식도암과 동반된 갑상선의 편평세포암종)

  • 홍기환;양윤수
    • Korean Journal of Bronchoesophagology
    • /
    • v.3 no.1
    • /
    • pp.154-158
    • /
    • 1997
  • A case of squamous cell carcinoma of the thyroid gland associated with esophageal carcinoma is presented A squamous cell carcinoma of the thyroid gland is rare and is prognosis is poor. The histogenesis of squamous cell carcinoma is not clear, but at present, it is believed that most cases arise from the follicular epithelium It is very important to know whether squamous cell carcinoma of the thyroid is primary or secondary. Thus, the possibility of squamous cell carcinoma in the thyroid being the result of a metastasis or extension from a primary tumor in the trachea or esophagus must always be ruled out and intensive evaluation should be required to confirm the diagnosis of this disease. We report a squamous cell carcinoma of the thyroid associated with esophageal cancer with brief review of literature.

  • PDF

A Case of Primary Squamous Cell Carcinoma of The Thyroid Gland (갑상선에서 발생한 원발성 편평상피세포암 1예)

  • Kang, Sihyung;Park, Gi Cheol
    • Korean Journal of Head & Neck Oncology
    • /
    • v.37 no.2
    • /
    • pp.91-95
    • /
    • 2021
  • Primary squamous cell carcinoma of thyroid is a very rare malignant tumor with poor prognosis. It is usually diagnosed as an advanced disease infiltrating adjacent organs, and characterized by aggressive clinical course with an average postoperative survival time of less than 1 year. Recently, we had a 79- year-old woman with a painful neck mass who was diagnosed as primary squamous cell carcinoma of thyroid gland. She underwent total thyroidectomy and selective neck dissection(level III, VI) with no further postoperative managements such as radiation therapy or chemotherapy; she died of poor general condition and pneumonia resulting from rapid progression of the lesion on the 38th day after surgery. We report this case with a review of relevant literatures.

Development of Parasol Device at Convenience Harvest Product for Chilli and Bare Ground Vegetable (고추 및 노지채소 수확작업 편이장치의 해가림 장치개발)

  • Jang, SukGeun;Kim, JiMan;Choi, Hwon;Kim, Yeoungsu;Oh, Sungkil;Lim, HackKyu;Kim, TeaHan
    • Proceedings of the Korean Society for Agricultural Machinery Conference
    • /
    • 2017.04a
    • /
    • pp.64-64
    • /
    • 2017
  • 노지 고추 수확작업은 7~9월에 걸쳐 5~6회 수행되며 가장 더운 한 여름의 태양볕에 노출되어 장시간 수확작업을 하며 노지채소 및 고추 수확작업시 자외선 과다 노출되어 악성흑생종, 광선각화증, 편평세포 암 및 각종 피부암발생의 원인되기 때문에 적절한 해가림 장치의 설계가 필요하다. 해를 가려주는 장치에 사용되는 재질로는 우산 및 양산에 널리 사용되어지는 섬유로 폴리에스테르를 선정하였으며 두께로 우산의 재질로 많이 사용되는 75 denier을 채택하였다. 코팅의 종류로는 Foam, Milky, Silver, 폴리우레탄을 채택하여 섬유의 코팅 종류에 따른 차단 효과를 실험하였다. 실험 방법으로서는 KS K 0850 텍스타일의 자외선 차단율 및 차단지수 시험방법에 의거 하여 실험하였다. 자외선 UV-A(365n/m), UV-B(315n/m) 측정장치는 자외선 센서, UV램프, 인디케이터로 구성된 측정기를 이용하였으며 각 재료별 5회 반복 실시하여 평균치를 산출 하였다. UV-A(365n/m) 측정값으로는 FOAM, MILKY코팅이 된 섬유재질이 KS의 우산 및 양산품질표시기준에 부합하여 해가림 장치에 사용이 적절하였으며 UV-B(315n/m) 파장 차단율 측정값으로는 KS의 우산 및 양산품질표시기준에 모두 부합되었다. 또한 해가림 장치는 태양고도에 따라 각도를 조절 가능한 형태로 설계하였으며 직사광선이 가장 강한 시간대인 10시부터 12시를 기준하여 틸팅의 최대 각도는 20도로 개발하였다. 또한 바람에 의한 날림현상을 방지하고 통풍효과를 높이기 위해서 해가림 장치의 섬유를 2중 구조로 설계하여 바람의 순환이 되게하였다.

  • PDF

Immunohistochemistry of Human Telomerase Reverse Transcriptase in Head and Neck Squamous Cell Carcinoma and Resection Margin (두경부 편평상피세포암과 절제연에서 Human Telomerase Reverse Transcriptase의 발현)

  • Kim Yong-Bum;Rho Kyung-Sup;Hong Nam-Pyo;Ahn Hwoe-Young;Lee Yong-Sik;Song Young-Ho
    • Korean Journal of Head & Neck Oncology
    • /
    • v.18 no.1
    • /
    • pp.18-22
    • /
    • 2002
  • Background and Objectives: The expression of telomerase, a ribonucleoprotein complex, has been detected in tissues from many human cancers, but not in the majority of normal tissues except germ cell. It is believed that the activation of telomerase is linked to celluar immortality and may playa role in tumorigenesis. Human telomerase reverse transcriptase (hTERT) has been identified as a putative catalytic subunit of human telomerase and its expression is closely correlated with telomease activity. We studied the expression of hTERT in head and neck squamous cell carcinoma (HNSCC) and resection margin by immunohistochemistry for hTERT and evaluate the correlation between hTERT expression and clinical data in HNSCC. Materials and Methods: We performed a immunohistochemistry in 17 cases of HNSCC and 10 cases of resection margins, histologically normal. The correlations between the hTERT expression and the clinical data in HNSCC were analyzed. Result: hTERT immunoreactivities were detected in 14 of 17 (82.4%) HNSCC, 1 of 10 (10%) resection margin. No correlation was observed between clinical data and hTERT expression in HNSCC. Conclusion: hTERT is activated in HNSCC and its expression is independent from clinical data of patients.

CD44 EXPRESSION IN ORAL SQUAMOUS CELL CARCINOMA (구강 편평세포 암종에서의 CD44 발현)

  • Park, Sang-Jun;Park, Hae-Ryoun;Kim, Gyoo-Cheon;Park, Bong-Soo;Kim, Tae-Kyu
    • Journal of the Korean Association of Oral and Maxillofacial Surgeons
    • /
    • v.26 no.2
    • /
    • pp.132-136
    • /
    • 2000
  • The cell surface glycoprotein CD44 is a kind of adhesion molecule, which binds hyaluronic acid, type I collagen and fibronectin. Although there have been numerous reports on the expression and the function of CD44 in lymphocytes and macrophages, very little is known about its distribution and definite role in epithelial tissue, especially in oral epithelial one. The present study was performed to investigate the distribution and expression of the CD44 in human gingiva and squamous cell carcinoma(SCC) arising in human gingiva. And the authors compared CD44 expression with histopathologic grade of SCC. The results were as follows: 1. The CD44 was strongly expressed in granular, spinous and basal layers of normal marginal and attached gingiva, in spinous and basal layers of normal sulcular gingiva, and in all epithelial layers of normal junctional gingiva. 2. In SCC of gingiva, the CD44 was expressed in all but one case. In most of the cases the CD44 was expressed at cell membrane and the degree of expression was relatively strong. 3. In low-grade SCC of gingiva, the CD44 was strongly expressed, especially at the basal and spinous layers of abundantly keratinized cancer nests. In high-grade SCC of gingiva, the CD44 expression tended to be weak but was strong at cells showing individual keratinization. This study suggest that the CD44 expression of normal and cancerous gingival epithelium is associated with the degree of proliferation and differentiation of epithelial cells.

  • PDF

Genomic Alterations in Korean Laryngeal Squamous Cell Carcinoma: Array-Comparative Genomic Hybridization (한국인 후두 편평 상피 세포암의 유전체 이상분석: Array 비교 유전체 보합법)

  • Cho, Yoon-Hee;Park, Soo-Yeun;Lee, Dong-Wook;Kim, Han-Su;Lee, Ja-Hyun;Park, Hae-Sang;Chung, Sung-Min
    • Korean Journal of Head & Neck Oncology
    • /
    • v.24 no.2
    • /
    • pp.155-161
    • /
    • 2008
  • Head and neck squamous cell carcinoma(HNSCC) still has poor outcome, and laryngeal cancer is the most frequent subtype of HNSCC. Therefore, there is a need to develop novel treatments to improve the outcome of patients with HNSCC. It is critical to gain further understanding on the molecular and chromosomal alteration of HNSCC to identify novel therapeutic targets but genetic etiology of squamous cell carcinoma of the larynx is so complex that target genes have not yet been clearly identified. Array based CGH(array-CGH) allows investigation of general changes in target oncogenes and tumor suppressor genes, which should, in turn, lead to a better understanding of the cancer process. In this study, We used genomic wide array-CGH in tissue specimens to map genomic alterations found in laryngeal squamous cell carcinomas. As results, gains of MAP2, EPHA3, EVI1, LOC389174, NAALADL2, USP47, CTDP1, MASP1, AHRR, and KCNQ5, with losses of SRRM1L, ANKRD19, FLJ39303, ZNF141, DSCAM, GPR27, PROK2, ARPP-21, and B3GAT1 were observed frequently in laryngeal squamous cell carcinoma tissue specimens. These data about the patterns of genomic alterations could be a basic step for understanding more detailed genetic events in the carcinogenesis and also provide information for diagnosis and treatment in laryngeal squamous cell carcinoma. The high resolution of array-CGH combined with human genome database would give a chance to find out possible target genes which were gained or lost clones.

The Result of the Surgical Treatment for Non-small Cell Lung Cancer (비소세포성 폐암의 외과적 치료에 대한 성적)

  • Park, Jin-Gyu;Jo, Jung-Gu;Kim, Gong-Su
    • Journal of Chest Surgery
    • /
    • v.30 no.9
    • /
    • pp.899-907
    • /
    • 1997
  • Recently, primary lung cancer has increased markedly in incidence & prevalence in korea. Prom July 1979 to June 1996, 183 patients were diagnosed and operated for primary non-small cell lung cancer, and evaluated clinically. 1. There were 164 males and 19 females(M:P=8.6: 1), and the peak incidence of age was 50th and 60th decade of life(73.7%). 2. Most of symptoms were respiratory, whitch were cough(44.8%), chest pain(30.1%), dyspnea(20.8%), hemoptysis or blood tinged sputum(19.7%), sputum(15.3%), and asymptomatic cases were 12.0%. 3. Histopathologically, sguamous cell carcinoma was 68.9%, adenocarcinoma 19.7%, bronchioloalveol r cell carcinoma 2.2%, adenosguamous cell carcinoma 1.6%, and large cell carcinoma 7.7%. 4. In the operation, pneumonectomy was 41.0%, lobectomy 42.1%, bilobectomy 13.1%, stagmentectomy or wedge resection 1.6%, and explore tharacotomy 2.2%, and the overall resectability was 97.8%. 5. Postoperative complications were developed in 31.9%, and operative mortality was 1.6%. 6. In postoperative stagings, stage I was 38.3%, stage H 14.8%, stage llla 31.1%, and stage IIIb 15.8%. 7. The overall cumulative survival rates were 1 year 77.8%, 3 year 42.7%, and 5 year 39.5%. The 5 year survival rate according to stage were stage 153.0%, stage H 46.5%, stage I[la 28.2%, and stage IIIb 13.8%(p<0.05), according to operation method were lobectomy 45.0%, and pneumonectomy 30.3%(p<0.05), and according to mediastinal involvement were Nl 32.0%, and N2 11.1%(p<0.05). The 5 year survival rate according to histologic type were squamous cell carcinoma 43.1%, adenocarcinoma 23.3%, and large cell carcinoma 30.3 (p>0.05).

  • PDF

Surgical Treatment of Stage IIIA Non Small Cell Lung Cancer(NSCLC) (제 IIIA기 비소세포 폐암의 수술 성적)

  • 정경영;홍기표;김창수;김길동;김주항;신동환
    • Journal of Chest Surgery
    • /
    • v.32 no.2
    • /
    • pp.144-150
    • /
    • 1999
  • Background: Surgery has been considered the most effective and standard treatment modality in non-small cell lung cancer(NSCLC). However in stage IIIA lung cancer, the role of surgery is still controversial. To evaluate the role of surgery for stage IIIA NSCLC, we investigated the survival after surgery and the prognostic factors. Material and Method: We evaluated 158 consecutive cases of stage IIIA NSCLC patients operated on between 1990 and 1996. There were 130 male patients and 28 female patients, and the mean age was 58.5 years. All patients except one underwent lung resection beyond lobectomy and extended mediastinal dissection. Postoperative adjuvant therapy were undertaken in 145(94.8%) patients. All patients(153) were followed and the mean follow-up period was 21.4months. Result: Twenty nine cases of the postoperative complications developed in 25 patients (15.8%). There were 5 operative mortality cases(3.2%) and the main cause of death was acute respiratory distress syndrome (ARDS). Local or distant recurrences developed in 84 patients(54.9%). The 5-year survival of 153 patients was 29.6% and the median survival time was 18.0 months. The 5-year survival of non N2 disease group(36.8%) was better than that of N2 disease group(26.6%)(p=0.35) and the 5-year survival of squamous cell carcinoma (38.1%) was better than that of adenocarcinoma(25.7%)(p=0.39) however there were no significant differences. Regarding the postoperative adjuvant therapy, in combined therapy group(84 patients), radiotherapy group(37 patients) and chemotherapy group(24 patients), the 5-year survival were 31.3%, 32.4%, and 14.6% respectively. There was no difference of survival between radiotherapy and combined therapy group(p=0.31), however the survival of the combined therapy group was better than the chemotherapy group(p=0.005). The survival of the complete resection group(31.9%) was better than the incomplete resection group(16.6%) however there was no significant difference(p=0.19). Conclusion: These observations indicate that the good 5-year survival(29.6%) in patients with stage IIIA NSCLC result from the agressive surgical treatment including extensive mediastinal nodes dissection.

  • PDF